(3R)-1-Oxo-3-methyl-8-hydroxy-3,4-dihydro-1H-2-benzopyran-5-carboxylic acid

Details

Top
Internal ID d94a871a-c93e-401c-a47f-3ff8fbd74aa6
Taxonomy Benzenoids > Benzene and substituted derivatives > Benzoic acids and derivatives > Phthalate esters > m-Phthalate esters
IUPAC Name (3R)-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-5-carboxylic acid
SMILES (Canonical) CC1CC2=C(C=CC(=C2C(=O)O1)O)C(=O)O
SMILES (Isomeric) C[C@@H]1CC2=C(C=CC(=C2C(=O)O1)O)C(=O)O
InChI InChI=1S/C11H10O5/c1-5-4-7-6(10(13)14)2-3-8(12)9(7)11(15)16-5/h2-3,5,12H,4H2,1H3,(H,13,14)/t5-/m1/s1
InChI Key QRLBIKRXEQOMSF-RXMQYKEDSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C11H10O5
Molecular Weight 222.19 g/mol
Exact Mass 222.05282342 g/mol
Topological Polar Surface Area (TPSA) 83.80 Ų
XlogP 2.00
Atomic LogP (AlogP) 1.19
H-Bond Acceptor 4
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
BDBM50524020
(3R)-1-Oxo-3-methyl-8-hydroxy-3,4-dihydro-1H-2-benzopyran-5-carboxylic acid

2D Structure

Top
2D Structure of (3R)-1-Oxo-3-methyl-8-hydroxy-3,4-dihydro-1H-2-benzopyran-5-carboxylic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9357 93.57%
Caco-2 - 0.6917 69.17%
Blood Brain Barrier - 0.8500 85.00%
Human oral bioavailability + 0.5714 57.14%
Subcellular localzation Mitochondria 0.7421 74.21%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9461 94.61%
OATP1B3 inhibitior + 0.9886 98.86%
MATE1 inhibitior - 0.7600 76.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior - 0.9814 98.14%
P-glycoprotein inhibitior - 0.9621 96.21%
P-glycoprotein substrate - 0.9168 91.68%
CYP3A4 substrate - 0.6611 66.11%
CYP2C9 substrate + 0.5914 59.14%
CYP2D6 substrate - 0.8917 89.17%
CYP3A4 inhibition - 0.8550 85.50%
CYP2C9 inhibition + 0.6710 67.10%
CYP2C19 inhibition - 0.8662 86.62%
CYP2D6 inhibition - 0.8619 86.19%
CYP1A2 inhibition - 0.5067 50.67%
CYP2C8 inhibition - 0.9299 92.99%
CYP inhibitory promiscuity - 0.9140 91.40%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.9413 94.13%
Carcinogenicity (trinary) Non-required 0.5688 56.88%
Eye corrosion - 0.9752 97.52%
Eye irritation + 0.9869 98.69%
Skin irritation - 0.5788 57.88%
Skin corrosion - 0.9037 90.37%
Ames mutagenesis - 0.6064 60.64%
Human Ether-a-go-go-Related Gene inhibition - 0.8011 80.11%
Micronuclear + 0.7359 73.59%
Hepatotoxicity + 0.7908 79.08%
skin sensitisation - 0.8782 87.82%
Respiratory toxicity + 0.6444 64.44%
Reproductive toxicity + 0.8556 85.56%
Mitochondrial toxicity + 0.7750 77.50%
Nephrotoxicity + 0.6119 61.19%
Acute Oral Toxicity (c) I 0.5330 53.30%
Estrogen receptor binding + 0.6974 69.74%
Androgen receptor binding - 0.4877 48.77%
Thyroid receptor binding - 0.7549 75.49%
Glucocorticoid receptor binding - 0.5765 57.65%
Aromatase binding - 0.8787 87.87%
PPAR gamma - 0.7354 73.54%
Honey bee toxicity - 0.9619 96.19%
Biodegradation - 0.5250 52.50%
Crustacea aquatic toxicity - 0.8000 80.00%
Fish aquatic toxicity + 0.8948 89.48%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.22% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.27% 95.56%
CHEMBL2581 P07339 Cathepsin D 93.73% 98.95%
CHEMBL1951 P21397 Monoamine oxidase A 93.07% 91.49%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 90.88% 99.23%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.18% 86.33%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 80.78% 99.15%
CHEMBL1806 P11388 DNA topoisomerase II alpha 80.61% 89.00%

Cross-Links

Top
PubChem 25769005
NPASS NPC226192
LOTUS LTS0116376
wikiData Q105226456